Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China national diabetes and metabolic disorders study
GLP-1 drugs likely to be helpful for additional indications October 22, 2025 Summary: New GLP-1 and related drugs are likely to become available over the next 3-5 years, and this drug class will likely be approved for additional indications
Their pleiotropic effects beyond glycemic control offer promising therapeutic opportunities in chronic skin diseases and plastic surgery, but also introduce unique challenges related to cutaneous adverse reactions, facial aging, surgical outcomes, and perioperative safety
[DOI] [PMC free article] [PubMed] [Google Scholar] 282.Manach C., Williamson G., Morand C., Scalbert A., Rmsy C
These studies reinforce what we observe clinically at Medical Specialists MN: for most patients seeking hormone optimization for wellness purposes, Sermorelin provides excellent results with fewer concerns than synthetic HGH
Diabetic neuropathy: a position statement by the American diabetes association
